| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/11/2006 | WO2005009965A8 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | WO2002055100A9 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100233 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
| 05/11/2006 | US20060100197 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation |
| 05/11/2006 | US20060100145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/11/2006 | US20060100141 Administering peptidic or peptidomimetic compound having segment competent for importation of molecule into mast cells, and asecond segment for having an anti-allergic effect within mast cells for reducing late phase inflammatory responses induced by mitogen activated protein kinase activation |
| 05/11/2006 | US20060100137 Monodispersed insulin polypeptide-oligomer conjugates; for administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099591 Diagnosis of chronic rejection |
| 05/11/2006 | US20060099276 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/11/2006 | US20060099219 Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 05/11/2006 | US20060099218 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 05/11/2006 | US20060099215 Walnut and ryegrass allergens |
| 05/11/2006 | US20060099212 treating or preventing a tumor necrosis factor-mediated disease by co-administering methotrexate and a TNF alpha antagonist |
| 05/11/2006 | US20060099176 Administering system for interferon, includes a first step for detecting the number of interferon receptors on a surface of the cell, a second step for administering interferon being prepared so that an interferon dosage is determined according to number of IFN receptors on the cell surface |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099150 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2586033A1 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 05/11/2006 | CA2584808A1 Substituted pyridines with activity on syk kinase |
| 05/11/2006 | CA2560559A1 Aqueous intraocular penetration-promoting eye drop |
| 05/10/2006 | EP1655372A2 Production of polyketides and other natural products |
| 05/10/2006 | EP1655307A1 Atopic dermatitis inducer |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655301A1 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon |
| 05/10/2006 | EP1655039A2 Immunoliposomes that optimize internalization into target cells |
| 05/10/2006 | EP1654238A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 05/10/2006 | EP1654234A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/10/2006 | EP1654229A1 Piperidine derivatives as ccr5 receptor modulators |
| 05/10/2006 | EP1653999A1 Compositions and methods for manipulating levels antigen-specific antibodies in a mammal |
| 05/10/2006 | EP1653998A2 Rabbit bacterium and uses thereof |
| 05/10/2006 | EP1653955A2 Hydroxylamine substituted imidazo-containing compounds |
| 05/10/2006 | EP1653952A2 Oxazole compounds for the treatment of neurodegenerative disorders |
| 05/10/2006 | EP1653914A2 Oxime substituted imidazo-containing compounds |
| 05/10/2006 | EP1483374B1 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vitro |
| 05/10/2006 | EP1432991A4 Identification and isolation of somatic stem cells and uses thereof |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1307189B1 Use of hydroxyethylrutosides for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1290136B1 Probiotics for pet food applications |
| 05/10/2006 | EP1265631B1 Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | EP1145001B1 (in vitro) model for gastrointestinal inflammation |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | EP1006782B1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
| 05/10/2006 | CN1771254A Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 05/10/2006 | CN1771226A 2-propylidene-19-nor-vitamin d compounds |
| 05/10/2006 | CN1769293A High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 05/10/2006 | CN1768784A Detoxifying, health-preserving, immunity-improving Chinese medicinal formulation and preparation method |
| 05/10/2006 | CN1768782A Method for preparing yang-strengthening, fatigue-relieving liquor with micron xylitol, ginseng, bull kidney, goat kidney, fur seal kidney, deer kidney, walnut kernel, pine pollen |
| 05/10/2006 | CN1768774A Aucklandia root oil containing emulsion, its preparation process and use |
| 05/10/2006 | CN1768766A Compound saline algae capsule |
| 05/10/2006 | CN1768759A Nkt cell-activating agents containing alpha-glycosylceramides |
| 05/10/2006 | CN1768752A Sustained release formulation with cetirizine and pseudoephedrine hydronate |
| 05/10/2006 | CN1768749A Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 05/10/2006 | CN1768586A Healthy ganoderma lucidum tea |
| 05/10/2006 | CN1255427C Method and composition for treating liver cell cancer |
| 05/10/2006 | CN1255424C Method for preparing injection ribonucleic acid of human placenta |
| 05/10/2006 | CN1255411C Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments |
| 05/10/2006 | CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
| 05/10/2006 | CN1255405C Substituted pyrazoles |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255182C Thymic peptide infusion and preparation process |
| 05/10/2006 | CN1255156C Medicine for treating lupus erythematosus, dermatomyositis, dermatos clerosis and sicca syndrome |
| 05/10/2006 | CN1255113C Cell growth regulating factor D and its preparation process |
| 05/10/2006 | CN1255112C Cell growth regulating factor E and its preparation process |
| 05/09/2006 | US7041813 Canine herpes virus alpha transinducing factor nucleic acid molecules |
| 05/09/2006 | US7041802 Peptidoglycan recognition proteins |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/09/2006 | US7041680 (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same |
| 05/09/2006 | US7041676 Compounds, compositions, and methods |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041665 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 05/09/2006 | US7041662 Substituted benzo [b] azepin-2-one compounds |
| 05/09/2006 | US7041652 administering ascorbic acid, ascorbate or a derivative thereof in combination with quercetin-3-O-glucoside (isoquercetin), quercetin-4'-glucoside, quercetin-3'-glucoside, or quercetin-7-glucoside to increase bioavailability |
| 05/09/2006 | US7041504 Cancer cell-inhibiting culture medium produced by culturing restricted entrapped cancer cells |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041322 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041294 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 05/09/2006 | US7041288 Antiinflammatory agents; antiallergens |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | US7040311 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2245588C Polysaccharide precipitation process |
| 05/09/2006 | CA2239489C 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity |
| 05/04/2006 | WO2006047256A1 Triazoles useful as inhibitors of protein kinases |
| 05/04/2006 | WO2006047172A1 Tweak receptor |